Europe CE Marking Regulatory Process for Medical Devices

Download the free chart: Europe Regulatory Approval Process for Medical DevicesIn order to commercialize medical devices in the European Union, a CE Mark certificate is needed. This certification verifies that a device meets all regulatory requirements of the Medical Devices Directive (MDD), or Active Implantable Medical Device Directive (AIMD) as they apply to your product. For a more detailed look at the European regulatory process for medical devices, download the chart below.

The European CE medical device approval process explained

The chart shown illustrates the CE approval process in Europe and is available for download in PDF format. However, if you would like to explain the steps to someone else in an email, you can cut and paste the text below or send them a link to this page.

Step 1
Determine which EU Medical Device Directive applies to your device: 93/42/EEC – Medical Devices Directive (MDD) or 90/385/EEC - Active Implantable Medical Devices Directive (AIMDD):

Step 2
Determine classification of your device using Annex IX of the Medical Devices Directive (MDD): Class I (non-sterile, non-measuring), Class I (sterile, measuring), Class IIa, Class IIb or Class III/AIMD. Active implantable medical devices are typically subject to the same regulatory requirements as Class III devices.

Step 3
For all devices except Class I (non-sterile, non-measuring), implement Quality Management System (QMS) in accordance with Annex II or V of the MDD.

Most companies apply the ISO 13485 standard to achieve QMS compliance.

For Class I (non-sterile, non-measuring), a QMS is not formally required. However a PMS procedure is required, though not likely to be audited by a Notified Body (NB).

Step 4
For Classes I through IIb, prepare a Technical File which provides detailed information on your medical device, and demonstrates compliance with 93/42/EEC.

For Class III/AIMD devices, prepare a Design Dossier.*

Step 5
Appoint an Authorized Representative (EC Rep) located in Europe. The EC Rep should be qualified to handle regulatory issues. Place EC REP name and address on Instructions for Use or outer packaging or device label.

Step 6
For all devices except Class I (non-sterile, non-measuring), your QMS and Technical File or Design Dossier must be audited by a Notified Body, a third party accredited by European authorities to audit medical device companies and products.

Step 7
For all devices except Class I (non-sterile, non-measuring), you will be issued a European CE Marking Certificate for your device and an ISO 13485 certificate for your facility following successful completion of your Notified Body audit. ISO 13485 certification must be renewed every year. CE Marking certificates are typically valid for 3 years.

Step 8
Prepare a Declaration of Conformity, a legally binding document prepared by the manufacturer stating that the device is in compliance with the applicable Directive. You may now affix the CE Marking.

Step 9
All Class I devices must be registered with the Competent Authority where your EC REP is based.

Some EU member states require additional registration of Class IIa, IIb or III devices which are placed on their markets.

Step 10
For Class I (non-sterile, non-measuring), CE Certificates do not expire. You must perform CER updates and PMS activities.

For all other classes, you will be audited each year by a Notified Body to ensure ongoing compliance with 93/42/EEC or 90/385/EEC. Failure to pass the audit will invalidate your CE Marking certificate. You must perform CER updates and PMS activities.

* All devices will require clinical data. Most of these data should refer to the subject device. Clinical studies are required for Class IIb and III implants. Existing clinical data may be acceptable. Clinical trials in Europe must be pre-approved by a European Competent Authority.

This is a simplified overview of the process. Your Notified Body may choose to audit your submission and request more documents, which will add time to your approval.

 

Chart updated: 21/02/2017